SEC Form 4 · accession 0001722024-17-000004
X4 Pharmaceuticals, Inc · XFOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexandria Venture Investments, LLC
10% Owner
Period of report
Nov 15, 2017
Accepted (ET)
Nov 20, 2017 · 10:01 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501697
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Nov 15, 2017 | C | 225,680 | — | A | 225,680 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series D convertible preferred stockF1,F2 | — | Nov 15, 2017 | C | 770,249 | D | Apr 24, 2017 | — | Common stock | 225,680 | 0 | D |
Explanation of responses
- F1Preferred shares are convertible at a ratio of 3.413 shares of preferred stock to 1 share of common stock
- F2Not applicable